查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631483

内视镜逆行性胰造影市场规模、份额、趋势分析报告：依产品类型、程序类型、最终用途、地区、细分市场、预测，2025-2030 年

Endoscopic Retrograde Cholangiopancreatography Market Size, Share & Trends Analysis Report By Product (Endoscopes, Endotherapy Devices), By Procedure Type (Biliary Sphincterotomy), By End-use (Hospitals), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

市场规模和趋势

2024 年全球内视镜逆行性造影市场规模估计为 21.7 亿美元，预计 2025 年至 2030 年的复合年增长率为 8.26%。这种增长主要是由于胆结石、胰臟炎和胆管阻塞等胰臟和胆道疾病的发生率不断上升，刺激了 ERCP 手术的需求。随着人口老化和生活方式的改变，这些疾病的盛行率预计会增加，从而推动市场成长。根据 2024 年 2 月发表在《临床胃肠病学和肝病学》上的一项研究，胆结石的全球整体盛行率估计为 6%，女性和南美洲的盛行率更高。根据研究，预计预测期内胆结石的盛行率将激增，从而推动对内视镜逆行性造影(ERCP) 手术的需求。

此外，内视镜技术的进步提高了 ERCP 手术的安全性和有效性。例如，2023年1月，研华推出了MIO-5377R单板计算机，作为内视镜技术领域的突破性创新。这款小巧、功能强大的设备旨在解决内视镜检查面临的传统挑战，以提高性能、可靠性和功能性。此外，高清影像、内视镜操作性的提高以及治疗附件的开发等技术创新使得ERCP成为一种更精确、有效的诊断和治疗工具。这些技术进步使得医疗保健提供者和患者都选择 ERCP 手术。

微创手术技术的日益普及推动了对 ERCP 手术的需求，预计这将在未来几年推动该行业的成长。例如，根据美国癌症协会2024年1月发布的年度报告，美国预计将诊断出41,630例新的肝癌病例。此外，根据同一资讯来源，与美国相比，东南亚和撒哈拉以南非洲国家的肝癌更为常见。此外，肝癌是全球癌症死亡的主要原因，每年夺走70万人以上的生命。

鑑于胆管癌和肝细胞癌的高负担，用于早期发现这些恶性肿瘤的内视镜逆行性造影的需求预计会增加。

此外，人们越来越意识到早期诊断和治疗胰臟和胆道疾病的好处，这也导致对 ERCP 等微创手术的需求增加。例如，2023 年 10 月，胆道闭锁意识委员会在豪登省固态器官移植科和威特沃特斯兰德大学夏洛特马克塞基学术医院的支持下发起了胆道闭锁意识宣传活动。这项宣传活动旨在意识提升并为他们提供支持。该倡议的重点是向不同人群普及胆道闭锁知识，为受影响的家庭提供研究和支持，促进诊断工具和治疗方法的研究，并促进与全球医疗保健组织的合作。

人口老化是推动内视镜逆行性造影市场成长的关键因素。随着世界人口不断老化，这些手术的需求日益增加，包括需要输血的手术。胆管病、贫血、手术止血等慢性病随着成年人口的增长而不断增加。目前，光是美国65岁以上的人口就超过4,000万，预计到2050年这数字将会翻倍。日本拥有世界上最大的老龄人口，为该市场提供了潜在的成长机会。根据世界卫生组织预测，2050年老龄人口比例预计将达到22.0%。

此外，一些医疗保健组织正在采取包括伙伴关係研究和开发创新产品的倡议，从而刺激市场成长。例如，根据 2022 年 7 月发表在《Optica Publishing Group》杂誌上的一项研究，生物医学工程与成像科学学院的研究人员开发了一种光声成像内视镜探头，可插入内径为 0.6 毫米的医疗针头。他还建议可以利用人工智慧（AI）来加快影像诊断速度。

此外，预计市场参与企业采取的併购和产品发布等策略性倡议将在预测期内推动市场发展。例如，2022 年 4 月，奥林巴斯与专注于开发止血领域技术的公司 EndoClot Plus 合作。 EndoClot Plus 的旗舰产品之一是 EndoClot PHS，一种非热、非创伤性的止消化道出血方法。该协议旨在使胃肠病学家更容易获得 EndoClot PHS，使他们能够在医疗过程中快速可靠地止血。

目录

第一章调查方法与范围

第 2 章执行摘要

经内视镜逆行性胆胰管摄影术市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 经内视镜逆行性胆胰管摄影术市场分析工具
    • 产业分析 – 波特五力分析
    • PESTEL 分析

经内视镜逆行性胆胰管摄影术市场：依产品分類的估计与趋势分析

  • 细分仪表板
  • 经内视镜逆行性胆胰管摄影术市场：产品差异分析
  • 经内视镜逆行性胆胰管摄影术市场前景（依产品）
  • 2018-2030 年市场规模、预测及趋势分析
  • 内视镜检查
  • 内视镜治疗装置
    • 括约肌切开术
    • 碎石机
    • 支架
    • 套管
    • 钳子
    • 勒除器
    • 导管
    • 导管导引线
    • 气球
    • 篮子
  • 视觉化系统
  • 能源设备
  • 其他的

经内视镜逆行性胆胰管摄影术市场：依手术类型进行的估计与趋势分析

  • 细分仪表板
  • 经内视镜逆行性胆胰管摄影术市场：手术类型变化分析
  • 经内视镜逆行性胆胰管摄影术市场前景（依手术类型）
  • 2018-2030 年市场规模、预测及趋势分析
  • 胆道括约肌切开术
  • 胆道支架
  • 胆管扩张
  • 胰臟括约肌切开术
  • 胰管支架置入术
  • 胰管扩张

经内视镜逆行性胆胰管摄影术市场：依最终用途的估计与趋势分析

  • 细分仪表板
  • 经内视镜逆行性胆胰管摄影术市场：最终用途变异分析
  • 经内视镜逆行性胆胰管摄影术市场前景（依最终用途）
  • 2018-2030 年市场规模、预测及趋势分析
  • 医院
  • 门诊设施

第七章经内视镜逆行性胆胰管摄影术市场：按地区估计与趋势分析

  • 区域控制面板
  • 经内视镜逆行性胆胰管摄影术市场波动分析
  • 经内视镜逆行性胆胰管摄影术市场：按技术和最终用途分類的区域估计和趋势分析
  • 2018-2030 年市场规模、预测及趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
    • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 市场参与企业分类
  • 主要企业简介
    • Olympus Corporation
    • CONMED Corporation
    • Boston Scientific Corporation
    • Medtronic PLC
    • Telemed System, Inc.
    • AMBU, Inc.
    • FUJIFILM Holdings Corporation
    • Hobbs Medical, Inc.
    • Cook Group
    • Streis PLC
    • HOYA Group
    • Karl Storz SE &Co. KG
Product Code: GVR-4-68040-327-5

Market Size & Trends:

The global endoscopic retrograde cholangiopancreatography market size was estimated at USD 2.17 billion in 2024 and is anticipated to grow at a CAGR of 8.26% from 2025 to 2030. This growth is majorly driven by the rising incidence of pancreatic and biliary diseases such as gallstones, pancreatitis, and bile duct obstructions are fueling the demand for ERCP procedures. As the population ages and lifestyles change, the prevalence of these conditions is expected to increase, driving market growth. According to Clinical Gastroenterology and Hepatology study published in February 2024, there is an estimated 6% prevalence of gallstones globally, with higher rates observed in females and in South America. According to studies, the incidence rate of gallstones is anticipated to rise sharply over the forecast period, thereby driving the demand for endoscopic retrograde cholangiopancreatography (ERCP) procedures.

Furthermore, advances in endoscopic technology have improved the safety and efficacy of ERCP procedures. For instance, in January 2023, Advantech introduced the MIO-5377R single board computer as a groundbreaking innovation in the field of endoscope technology. This compact and powerful device is designed to address the traditional challenges faced by endoscopes, offering enhanced performance, reliability, and functionality. Moreover, innovations such as high-definition imaging, better maneuverability of endoscopes, and the development of therapeutic accessories have made ERCP a more precise and effective diagnostic and treatment tool. These technological advancements are attracting both healthcare providers and patients to opt for ERCP procedures.

The rise in the adoption of minimally invasive surgical techniques has led to an increased demand for ERCP procedures, which is expected to drive growth in the industry in the upcoming years. For instance, according to the American Cancer Society's annual report published in January 2024, an estimated 41,630 new cases of liver cancer are expected to be diagnosed in the U.S. Additionally, as per the same source, liver cancer is more prevalent in countries in sub- Southeast Asia and Saharan Africa compared to the U.S. It is the most common type of cancer in many of these nations, with over 800,000 new cases diagnosed globally each year. Additionally, liver cancer ranks as a leading cause of cancer-related deaths worldwide, claiming more than 700,000 lives annually.

The high burden of cholangiocarcinoma and hepatocellular carcinoma is expected to boost the demand for endoscopic retrograde cholangiopancreatography for the early detection of such malignancies.

Moreover, the increased awareness about the benefits of early diagnosis and treatment of pancreatic and biliary diseases has led to a higher demand for minimally invasive procedures such as ERCP. For instance, in October 2023. the Biliary Atresia Awareness Committee launched Biliary Atresia Awareness Campaign under the auspices of Gauteng Provincial Solid Organ Transplant Division and the University of the Witwatersrand at Charlotte Maxeke Academic Hospital. The campaign was aimed to raise awareness and support for children affected by biliary atresia, a rare and life-threatening liver disease that affects infants by obstructing or obliterating bile ducts. The initiative was focused on educating diverse demographics about biliary atresia, offering resources and support to affected families, advancing research for diagnostic tools and treatments, and fostering collaboration with medical entities globally.

The aging population is a significant factor driving the growth of the endoscopic retrograde cholangiopancreatography market. As the global population continues to age, there is a growing demand for these procedures, including surgeries that require blood transfusions. Chronic diseases such as caugulopathy, anemia, and surgical blood seeking continue to increase along with the increase in adult population. Currently , there are over 40 million people in the U.S. alone above 65 years and the number are expected to double by 2050. Japan provides potential growth opportunities to this market due to the presence of the highest geriatric population in the globe. According to WHO, the percentage of the geriatric population is expected to reach 22.0% by 2050.

Additionally, several healthcare organizations are adopting initiatives including partnerships for the R&D of innovative products, thereby fueling the market growth. For instance , according to research study published in Optica Publishing Group journal in July 2022, researchers at the School of Biomedical Engineering & Imaging Sciences developed a photoacoustic imaging endoscope probe which can be inserted into a medical needle with an inner diameter as small as 0.6 millimeters. They also suggested that artificial intelligence (AI) could be utilized to accelerate imaging procedures.

Furthermore, the strategic initiatives adopted by the market players, such as mergers, and acquisitions, and product launches are projected to drive the market over the forecast period. For instance, in April 2022, Olympus partnered with EndoClot Plus, a company that focuses on developing technologies in the hemostasis space. One of the key products in EndoClot Plus' portfolio is the EndoClot PHS, a nonthermal, nontraumatic method for achieving hemostasis with gastrointestinal (GI) bleeds. This agreement aims to make the EndoClot PHS more accessible to gastroenterologists, enabling them to stop bleeding rapidly and reliably during medical procedures.

Global Endoscopic Retrograde Cholangiopancreatography Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global endoscopic retrograde cholangiopancreatography market report based on product, procedure, end use and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Endoscopes
  • Endotherapy Devices
    • Sphincterotomes
    • Lithotripter
    • Stents
    • Cannulas
    • Forceps
    • Snares
    • Catheters
    • Guiding Wires
    • Balloons
    • Baskets
  • Visualization Systems
  • Energy Devices
  • Others
  • Procedure Outlook (Revenue, USD Million, 2018 - 2030)
  • Biliary Sphincterotomy
  • Biliary Stenting
  • Biliary Dilatation
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Stenting
  • Pancreatic Duct Dilation
  • End use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Outpatient Facilities
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Sweden
    • Denmark
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Procedure
    • 1.2.3. End use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Procedure outlook
    • 2.2.3. End use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Endoscopic Retrograde Cholangiopancreatography Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Endoscopic Retrograde Cholangiopancreatography Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Endoscopic Retrograde Cholangiopancreatography Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Endoscopic Retrograde Cholangiopancreatography Market: Product Movement Analysis
  • 4.3. Endoscopic Retrograde Cholangiopancreatography Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Endoscopes
    • 4.5.1. Endoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Endotherapy Devices
    • 4.6.1. Endotherapy Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Sphincterotomes
      • 4.6.2.1. Sphincterotomes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Lithotripter
      • 4.6.3.1. Lithotripter Market Revenue Estimates and Fo recasts, 2018 - 2030 (USD Million)
    • 4.6.4. Stents
      • 4.6.4.1. Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.5. Cannulas
      • 4.6.5.1. Cannulas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.6. Forceps
      • 4.6.6.1. Forceps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.7. Snares
      • 4.6.7.1. Snares Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.8. Catheters
      • 4.6.8.1. Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.9. Guiding Wires
      • 4.6.9.1. Guiding Wires Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.10. Balloons
      • 4.6.10.1. Balloons Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.11. Baskets
      • 4.6.11.1. Baskets Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Visualization Systems
    • 4.7.1. Visualization Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Energy Devices
    • 4.8.1. Energy Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Endoscopic Retrograde Cholangiopancreatography Market: Procedure Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Endoscopic Retrograde Cholangiopancreatography Market: Procedure Movement Analysis
  • 5.3. Endoscopic Retrograde Cholangiopancreatography Market by Procedure Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Biliary Sphincterotomy
    • 5.5.1. Biliary Sphincterotomy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Biliary Stenting
    • 5.6.1. Biliary Stenting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Biliary Dilatation
    • 5.7.1. Biliary Dilatation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Pancreatic Sphincterotomy
    • 5.8.1. Pancreatic Sphincterotomy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Pancreatic Duct Stenting
    • 5.9.1. Pancreatic Duct Stenting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Pancreatic Duct Dilation
    • 5.10.1. Pancreatic Duct Dilation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Endoscopic Retrograde Cholangiopancreatography Market: End use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Endoscopic Retrograde Cholangiopancreatography Market: End use Movement Analysis
  • 6.3. Endoscopic Retrograde Cholangiopancreatography Market by End use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Outpatient Facilities
    • 6.6.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Endoscopic Retrograde Cholangiopancreatography Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Endoscopic Retrograde Cholangiopancreatography Market movement analysis
  • 7.3. Endoscopic Retrograde Cholangiopancreatography Market: Regional Estimates & Trend Analysis by Technology & End use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. North America
    • 7.5.1. North America Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Europe
    • 7.5.6. Europe Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. UK
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. UK Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Germany
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement scenario
      • 7.5.8.5. Germany Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. France
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement scenario
      • 7.5.9.5. France Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.10. Italy
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement scenario
      • 7.5.10.5. Italy Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.11. Spain
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement scenario
      • 7.5.11.5. Spain Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.12. Denmark
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement scenario
      • 7.5.12.5. Denmark Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.13. Sweden
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement scenario
      • 7.5.13.5. Sweden Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.14. Norway
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Competitive Scenario
      • 7.5.14.3. Regulatory Framework
      • 7.5.14.4. Reimbursement scenario
      • 7.5.14.5. Norway Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Japan Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. China Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. India Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. South Korea Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Australia Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Thailand Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Brazil Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Argentina Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. South Africa Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. UAE Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Kuwait Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Olympus Corporation
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. CONMED Corporation
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Boston Scientific Corporation
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Medtronic PLC
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Telemed System, Inc.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. AMBU, Inc.
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. FUJIFILM Holdings Corporation
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Hobbs Medical, Inc.
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Cook Group
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Streis PLC
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. HOYA Group
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives
    • 8.2.12. Karl Storz SE & Co. KG
      • 8.2.12.1. Company overview
      • 8.2.12.2. Financial performance
      • 8.2.12.3. Product benchmarking
      • 8.2.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 5 Global Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America Endoscopic Retrograde Cholangiopancreatography market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 9 North America Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 12 U.S. Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Mexico Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 14 Mexico Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 15 Mexico Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million
  • Table 16 Canada Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 18 Canada Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe Endoscopic Retrograde Cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 22 Europe Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 24 UK Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 25 UK Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Germany Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 27 Germany Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 28 Germany Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 30 France Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 31 France Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 34 Italy Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 37 Spain Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Norway Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 39 Norway Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 40 Norway Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 42 Sweden Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 43 Sweden Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Denmark Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 45 Denmark Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 46 Denmark Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Japan Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 52 Japan Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 53 Japan Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 54 China Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 55 China Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 56 China Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 58 India Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 59 India Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 61 Australia Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 62 Australia Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 63 South Korea Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 64 South Korea Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 65 South Korea Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 67 Thailand Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 68 Thailand Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America Endoscopic Retrograde Cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 71 Latin America Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 72 Latin America Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 75 Brazil Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 78 Argentina Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 84 South Africa Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 85 South Africa Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 90 UAE Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 91 UAE Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Endoscopic Retrograde Cholangiopancreatography market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Endoscopic Retrograde Cholangiopancreatography market, product outlook key takeaways (USD Million)
  • Fig. 12 Endoscopes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Endotherapy devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Sphincterotomes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Lithotripter market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Stents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Cannulas market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Forceps market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Snares market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Catheters market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Guiding wires market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Balloons market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Baskets market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Visualization systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Energy devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Endoscopic Retrograde Cholangiopancreatography market, Procedure outlook key takeaways (USD Million)
  • Fig. 28 Endoscopic Retrograde Cholangiopancreatography market: Procedure movement analysis 2023 & 2030 (USD Million)
  • Fig. 29 Biliary sphincterotomy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Biliary stenting market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Biliary dilatation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Pancreatic sphincterotomy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Pancreatic duct stenting market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Pancreatic duct dilation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Endoscopic Retrograde Cholangiopancreatography market, end use outlook key takeaways (USD Million)
  • Fig. 36 Endoscopic Retrograde Cholangiopancreatography market: end use movement analysis 2023 & 2030 (USD Million)
  • Fig. 37 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Outpatient facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Endoscopic Retrograde Cholangiopancreatography market: Regional key takeaways (USD Million)
  • Fig. 40 Endoscopic Retrograde Cholangiopancreatography market: regional outlook, 2023 & 2030, USD Million
  • Fig. 41 North America Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Canada Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Mexico Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Europe Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 UK Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Germany Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 France Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Spain Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Italy Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Norway Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 China Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Japan Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 India Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Australia Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Thailand Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Latin America Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Brazil Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Argentina Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Middle East and Africa Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 South Africa Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 UAE Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Kuwait Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 List of key emerging company's/technology disruptors/innovators